As of March 31, 2026, Alibaba Health Information Technology Ltd. carries a market capitalization of 10.15B, placing it among publicly traded companies globally. Its enterprise value stands at 8.98B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 10.15B |
| Enterprise Value | 8.98B |
Alibaba Health Information Technology Ltd.'s next confirmed earnings release is scheduled for December 1, 2026.
| Earnings Date | 12/1/2026 |
As of March 31, 2026, Alibaba Health Information Technology Ltd. has 16.18B shares outstanding.
| Shares Outstanding | 16.18B |
These figures are as of March 31, 2026.
| PB Ratio | 4.91 |
| P/TBV Ratio | 5.22 |
As of March 31, 2026, Alibaba Health Information Technology Ltd. maintains a current ratio of 3.03, meaning it holds 3.0x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 3.03 |
| Quick Ratio | 2.00 |
| Debt / Equity | 0.33 |
These figures cover the twelve months ended March 31, 2026.
| Employee Count | 1,379.00 |
As of the close on October 7, 2026, Alibaba Health Information Technology Ltd.'s stock has declined approximately 37.79% over the past 52 weeks.
| 52-Week Price Change | -37.79% |
As of March 31, 2026, Alibaba Health Information Technology Ltd. holds 1.18B in cash and equivalents against 6.92M in total debt, resulting in a net debt position of -629.02M. Total book value stands at 2.07B, with working capital of 1.20B providing operational flexibility.
| Cash & Cash Equivalents | 1.18B |
| Total Debt | 6.92M |
| Net Debt | -629.02M |
| Equity (Book Value) | 2.07B |
| Book Value Per Share | 0.13 |
| Working Capital | 1.20B |
Already premium?